Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

Metastatic breast cancer can come with many physical changes that can be noticeable and impact daily functioning, but there ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Virtual reality has been a standout technology in the medical industry since the turn of the decade. From its use as a ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...